DK0763057T3 - Fremgangsmåde til proliferering og differentiering af B celler og anvendelse deraf - Google Patents

Fremgangsmåde til proliferering og differentiering af B celler og anvendelse deraf

Info

Publication number
DK0763057T3
DK0763057T3 DK95918912T DK95918912T DK0763057T3 DK 0763057 T3 DK0763057 T3 DK 0763057T3 DK 95918912 T DK95918912 T DK 95918912T DK 95918912 T DK95918912 T DK 95918912T DK 0763057 T3 DK0763057 T3 DK 0763057T3
Authority
DK
Denmark
Prior art keywords
cells
proliferating
differentiating
present
provides methods
Prior art date
Application number
DK95918912T
Other languages
Danish (da)
English (en)
Inventor
Marilyn Kehry
Brian E Castle
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK0763057T3 publication Critical patent/DK0763057T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0635—B lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/52—CD40, CD40-ligand (CD154)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK95918912T 1994-04-28 1995-04-28 Fremgangsmåde til proliferering og differentiering af B celler og anvendelse deraf DK0763057T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23458094A 1994-04-28 1994-04-28

Publications (1)

Publication Number Publication Date
DK0763057T3 true DK0763057T3 (da) 2006-03-27

Family

ID=22881963

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95918912T DK0763057T3 (da) 1994-04-28 1995-04-28 Fremgangsmåde til proliferering og differentiering af B celler og anvendelse deraf

Country Status (10)

Country Link
US (2) US5817516A (fr)
EP (1) EP0763057B1 (fr)
JP (1) JP3881691B2 (fr)
AT (1) ATE309267T1 (fr)
CA (1) CA2188165C (fr)
DE (1) DE69534595T2 (fr)
DK (1) DK0763057T3 (fr)
ES (1) ES2251719T3 (fr)
MX (1) MX9605088A (fr)
WO (1) WO1995029935A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962406A (en) * 1991-10-25 1999-10-05 Immunex Corporation Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same
US7405270B2 (en) * 1991-10-25 2008-07-29 Immunex Corporation CD40-Ligand lacking native-pattern glycosylation
CA2188165C (fr) * 1994-04-28 2007-08-28 Marilyn Kehry Methode de multiplication et differenciation des cellules b et leur utilisation
WO1998021314A2 (fr) * 1996-11-12 1998-05-22 Dana-Farber Cancer Institute Procede servant a stimuler l'activation et la proliferation de lymphocytes b et a moduler des reactions immunitaires
US6465251B1 (en) 1996-11-13 2002-10-15 Dana-Farber Cancer Institute, Inc. Method of promoting b-cell proliferation and activation with CD40 ligand and cyclosporin
US7070771B1 (en) 1996-12-09 2006-07-04 Regents Of The University Of California Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
EP2039368A3 (fr) 1999-04-30 2009-04-01 La Jolla Institute For Allergy And Immunology Procédé pour empêcher la réactivation d'un virus latent et contrôler la réplication du virus
US7786282B2 (en) * 2001-12-06 2010-08-31 The Regents Of The University Of California Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
ES2384960T3 (es) * 2001-12-18 2012-07-16 Cancer Research Technology Limited Procedimiento para la generación de líneas celulares proliferativas y que se diferencian
US7495090B2 (en) * 2002-05-23 2009-02-24 The Regents Of The University Of California Nucleic acids encoding chimeric CD154 polypeptides
ES2354610T5 (es) * 2002-12-23 2020-09-14 Bristol Myers Squibb Co Mejora de la calidad del producto en procedimientos de cultivo de células de mamífero para la producción de proteína
AU2005325801A1 (en) * 2005-01-31 2006-08-03 Ablynx N.V. Method for generating variable domain sequences of heavy chain antibodies
ATE505535T1 (de) 2005-08-23 2011-04-15 Iq Corp Verfahren zur herstellung stabiler b-lymphozyten
HUE047164T2 (hu) * 2007-11-01 2020-04-28 Univ Arkansas Kompozíciók és eljárások eimeria elleni immunválasz fokozására
CA2738176C (fr) * 2008-09-23 2012-01-10 Hema-Quebec Procede pour la fabrication d'immunoglobulines g polyclonales par des lymphocytes b humains
JP5550132B2 (ja) 2009-10-30 2014-07-16 学校法人東京理科大学 抗原特異的ｂ細胞集団の製造方法
MY173328A (en) 2013-02-14 2020-01-16 Texas A & M Univ Sys Compositions and methods of enhancing immune responses to eimeria or limiting eimeria infection
JP6684211B2 (ja) 2014-07-02 2020-04-22 学校法人東京理科大学 Ｂ細胞集団の製造方法
US11043823B2 (en) * 2017-04-06 2021-06-22 Tesla, Inc. System and method for facilitating conditioning and testing of rechargeable battery cells
KR102539610B1 (ko) * 2020-01-22 2023-06-02 한국생명공학연구원 메모리 b 세포 특이적 분화 유도 방법 및 이의 활용
WO2022225862A1 (fr) * 2021-04-19 2022-10-27 Walking Fish Therapeutics Procédés d'expansion de lymphocytes b destinés à être utilisés dans la thérapie cellulaire

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989008114A1 (fr) 1988-02-25 1989-09-08 The General Hospital Corporation Procede de clonage par immunoselection rapide
EP0434879A1 (fr) 1989-12-14 1991-07-03 Schering-Plough Méthode de production de lignées de cellules B humaines dépendantes d'un facteur
JPH06500023A (ja) 1991-05-16 1994-01-06 イーデーテー　アーゲー　フュア　イン　ビーフォ　ディアグノスティーク　ウント　テラピー 抗原特異性ｂおよびｔリンパ球ならびにそれから得られるモノクローナル抗体を提供する方法
JP3308534B2 (ja) 1991-10-25 2002-07-29 イミュネックス・コーポレーション 新規なサイトカイン
US5474771A (en) 1991-11-15 1995-12-12 The Trustees Of Columbia University In The City Of New York Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes, compositions containing same
CA2089229C (fr) 1992-02-14 2010-04-13 Alejandro A. Aruffo Recepteur cd40cr et ligands pour celui-ci
DE4322330A1 (de) 1992-08-31 1994-03-03 Behringwerke Ag Verwendung des IL-4-Rezeptors zur Therapie, Prophylaxe und Diagnose von allergischen, viralen, parasitären und bakteriellen Erkrankungen sowie von Pilzinfektionen
US5516657A (en) * 1992-05-11 1996-05-14 Cambridge Biotech Corporation Baculovirus vectors for expression of secretory and membrane-bound proteins
AU5098493A (en) 1992-08-21 1994-03-15 Schering Corporation Cd40 ligand, anti cd40 antibodies, and soluble cd40
US5540926A (en) 1992-09-04 1996-07-30 Bristol-Myers Squibb Company Soluble and its use in B cell stimulation
CA2188165C (fr) * 1994-04-28 2007-08-28 Marilyn Kehry Methode de multiplication et differenciation des cellules b et leur utilisation

Also Published As

Publication number Publication date
MX9605088A (es) 1997-08-30
CA2188165C (fr) 2007-08-28
EP0763057A4 (fr) 1998-11-11
JPH09512441A (ja) 1997-12-16
EP0763057A1 (fr) 1997-03-19
US5817516A (en) 1998-10-06
US6297052B1 (en) 2001-10-02
WO1995029935A1 (fr) 1995-11-09
DE69534595D1 (de) 2005-12-15
EP0763057B1 (fr) 2005-11-09
ATE309267T1 (de) 2005-11-15
DE69534595T2 (de) 2006-05-24
CA2188165A1 (fr) 1995-11-09
ES2251719T3 (es) 2006-05-01
JP3881691B2 (ja) 2007-02-14

Similar Documents

Publication Publication Date Title
DK0763057T3 (da) Fremgangsmåde til proliferering og differentiering af B celler og anvendelse deraf
DK455084A (da) Fremgangsmaade og anlaeg til kondensering af naturgas
DK156904C (da) Akustikplade og fremgangsmaade til fremstilling af samme
DK0807166T3 (da) Metode til forberedelse af en udifferentieret celle
NO975557D0 (no) Immortalisering og dismortalisering av celler
DK526783A (da) Forbedret stamme af clostridium acetobutylicum og fremgangsmaade til fremstilling af samme
DK226477A (da) Fremgangsmade til massedyrkning af celler og kammersystem til udovelse af fremgangsmaden
TW358962B (en) Method for designing an architectural system
DK276780A (da) Fremgangsmaade til fremstilling af hydrogenholdig gas
DK463587D0 (da) Fremgangsmaade og middel til fremstilling af mikroorganismecellemasse
DK494188D0 (da) Aetermoplast-formstykker, samt fremgangsmaade til fremstilling af disse
DK333181A (da) Fremgangsmaade og apparat til produktion af gas udfra isaer landbrugsaffaldsstoffer
DK286784A (da) Fremgangsmaade og system til produktion af naturgas fra broende paa havbunden
DE3780855T2 (de) Zellkultur-methode.
DK396585A (da) Fremgangsmaade og anlaeg til dyrkning af mikroorganismer
DK439086A (da) Fremgangsmaader til anvendelse af cellelinier, der mangler humane klasseii histokompatibilitetsantigener
DK95391A (da) Fremgangsmaade til fremstilling af hydrogenholdig gas
DK246284D0 (da) Fremgangsmaade og middel til isolering af elementer af hvide blodlegemer
DK319682A (da) Fremgangsmaade til reduktion af gastryk i et elektrokemisk element
DK212284D0 (da) Fremgangsmaade til fremstilling af 20-keto-delta 16-steroider og mellemprodukter dannet ved denne fremgangsmaade
IT1136191B (it) Procedimento per la preparazione di lievito naturale allo stato granulato fine trasportabile e conservabile nel tempo
DK27282A (da) Heparinnetvaerk og fremgangsmaade til fremstilling deraf
DK576286D0 (da) Fremgangsmaade til halvkontinuerlig metabolitproduktion ved hjaelp af planteceller, dyrket in vitro
DK152264C (da) Fremgangsmaade og kniv til kloevning af fiberplader.
DK0403015T3 (da) Fremgangsmåde til dyrkning af celler